Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GNPX Genprex, Inc.

盘后交易 02-04 18:32:23 EST

2.21

-0.19

-7.92%

盘后2.25

+0.04+1.81%

18:03 EST

最高2.42	最低2.18	成交量29.04万
今开2.41	昨收2.40	日振幅10.00%
总市值512.48万	流通市值501.27万	总股本231.89万
成交额65.72万	换手率12.80%	流通股本226.82万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":2.21,"timestamp":1770238800000,"preClose":2.4,"halted":0,"volume":290360,"hourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.21,"latestTime":"18:03 EST","volume":1431,"amount":3202.9145712,"timestamp":1770246183465,"change":0.04,"changeRate":0.0181,"amplitude":0.076923},"delay":0,"changeRate":-0.07916666666666665,"floatShares":2268200,"shares":2318900,"eps":-37.32179,"marketStatus":"盘后交易","change":-0.19,"latestTime":"02-04 18:32:23 EST","open":2.41,"high":2.42,"low":2.18,"amount":657156.805424,"amplitude":0.1,"askPrice":2.39,"askSize":200,"bidPrice":2.18,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-37.32179,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770253200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":2.4,"preHourTrading":{"tag":"盘前","latestPrice":2.4124,"preClose":2.4,"latestTime":"09:27 EST","volume":11543,"amount":26890.070679499997,"timestamp":1770215220823,"change":0.0124,"changeRate":0.005167,"amplitude":0.070792},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.21,"latestTime":"18:03 EST","volume":1431,"amount":3202.9145712,"timestamp":1770246183465,"change":0.04,"changeRate":0.0181,"amplitude":0.076923},"volumeRatio":0.134062,"impliedVol":3.1839,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"2609113293","title":"Genprex, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609113293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609113293?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:47","pubTimestamp":1770216442,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时47分，Genprex, Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报2.28美元/股，成交量6.3778万股，换手率2.81%，振幅5.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020422472297a4e091&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020422472297a4e091&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"1180959835","title":"Genprex公布Gpx-002在2型糖尿病动物研究中的积极临床前初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1180959835","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180959835?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:01","pubTimestamp":1767700877,"startTime":"0","endTime":"0","summary":"生物技术公司Genprex, Inc.近日披露了其候选药物Gpx-002在2型糖尿病动物模型中取得的积极初步临床前研究结果。该数据显示，Gpx-002在改善糖尿病相关关键指标方面表现出潜力，为后续开发提供了支持。公司计划基于这些数据推进进一步的研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2584185808","title":"Genprex, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584185808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584185808?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:38","pubTimestamp":1763563132,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日22时38分，Genprex, Inc.股票出现波动，股价大幅下挫5.13%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111922385297739f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111922385297739f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"1186689338","title":"Genprex获得美国专利，针对Reqorsa®基因疗法与Pd-L1抗体联合治疗癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=1186689338","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186689338?lang=zh_cn&edition=full","pubTime":"2025-11-18 20:01","pubTimestamp":1763467275,"startTime":"0","endTime":"0","summary":"Genprex获得美国专利，针对Reqorsa®基因疗法与Pd-L1抗体联合治疗癌症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2579088041","title":"Genprex, Inc.盘中异动 下午盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579088041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579088041?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:49","pubTimestamp":1761850178,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日02时49分，Genprex, Inc.股票出现异动，股价急速跳水5.09%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031024938a47e591d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031024938a47e591d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"1147059589","title":"Genprex宣布按照纳斯达克规则进行高达1000万美元的注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1147059589","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147059589?lang=zh_cn&edition=full","pubTime":"2025-10-28 23:23","pubTimestamp":1761664997,"startTime":"0","endTime":"0","summary":"Genprex宣布按照纳斯达克规则进行高达1000万美元的注册直接发行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"1138340802","title":"Genprex 宣布根据纳斯达克规则进行高达810万美元的注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1138340802","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138340802?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:13","pubTimestamp":1761221591,"startTime":"0","endTime":"0","summary":"Genprex 宣布根据纳斯达克规则进行高达810万美元的注册直接发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"1151035663","title":"Genprex合作者将在2025年AACR-NCI-EROTC国际分子靶点与癌症疗法会议上展示Reqorsa®基因疗法治疗肺癌的积极前临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1151035663","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151035663?lang=zh_cn&edition=full","pubTime":"2025-10-23 19:01","pubTimestamp":1761217278,"startTime":"0","endTime":"0","summary":"Genprex合作者将在2025年AACR-NCI-EROTC国际分子靶点与癌症疗法会议上展示Reqorsa®基因疗法治疗肺癌的积极前临床数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2575752781","title":"Genprex, Inc.盘中异动 股价大涨105.90%报0.520美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575752781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575752781?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:34","pubTimestamp":1760535274,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时34分，Genprex, Inc.股票出现波动，股价大幅拉升105.90%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015213434a46180f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015213434a46180f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2574197725","title":"Genprex, Inc.盘中异动 早盘股价大跌5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574197725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574197725?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:31","pubTimestamp":1760016715,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时31分，Genprex, Inc.股票出现波动，股价大幅跳水5.81%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100921315594c090be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100921315594c090be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2573391919","title":"Genprex, Inc.盘中异动 临近午盘大幅拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573391919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573391919?lang=zh_cn&edition=full","pubTime":"2025-10-06 23:32","pubTimestamp":1759764728,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日23时32分，Genprex, Inc.股票出现异动，股价大幅拉升5.11%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006233208a4554424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006233208a4554424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2572783963","title":"Genprex, Inc.盘中异动 早盘大幅上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572783963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572783963?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:40","pubTimestamp":1759239605,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时40分，Genprex, Inc.股票出现异动，股价急速拉升5.50%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930214005971a6b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930214005971a6b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2563857698","title":"Genprex, Inc.盘中异动 临近午盘急速下跌5.04%报0.166美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2563857698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563857698?lang=zh_cn&edition=full","pubTime":"2025-08-29 23:46","pubTimestamp":1756482390,"startTime":"0","endTime":"0","summary":"北京时间2025年08月29日23时46分，Genprex, Inc.股票出现异动，股价急速下跌5.04%。截至发稿，该股报0.166美元/股，成交量153.249万股，换手率4.58%，振幅7.96%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829234630a4a8336a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829234630a4a8336a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2561408379","title":"Genprex, Inc.盘中异动 早盘大幅拉升16.20%报0.167美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561408379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561408379?lang=zh_cn&edition=full","pubTime":"2025-08-22 21:31","pubTimestamp":1755869496,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日21时31分，Genprex, Inc.股票出现波动，股价急速拉升16.20%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822213136a6f5a364&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822213136a6f5a364&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2514522378","title":"Genprex, Inc.盘中异动 大幅上涨5.33%报0.395美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514522378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514522378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:38","pubTimestamp":1740753502,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时38分，Genprex, Inc.股票出现异动，股价大幅拉升5.33%。截至发稿，该股报0.395美元/股，成交量4.8375万股，换手率0.57%，振幅1.39%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223822a2580314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223822a2580314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2514851687","title":"Genprex, Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851687?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:53","pubTimestamp":1740581593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时53分，Genprex, Inc.股票出现波动，股价大幅上涨5.44%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225313a254fc08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225313a254fc08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2513656773","title":"Genprex, Inc.盘中异动 早盘急速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513656773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513656773?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:47","pubTimestamp":1740412041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时47分，Genprex, Inc.股票出现波动，股价快速下挫5.88%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234722a2522674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234722a2522674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2512848369","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512848369?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:44","pubTimestamp":1739976264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时44分，Genprex, Inc.股票出现波动，股价急速跳水5.27%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224424988b33e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224424988b33e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2512165056","title":"Genprex, Inc.盘中异动 股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165056?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Genprex, Inc.股票出现波动，股价大幅跳水5.65%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223140a24aac82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223140a24aac82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2511851526","title":"Genprex, Inc.股价拉升12.82% 市值涨58.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511851526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511851526?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457068,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Genprex, Inc.股票出现异动，股价大幅拉升12.82%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.17%、765.03%、89.78%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.，振幅分别为7.80%、4.53%、4.03%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":0.0169},{"period":"1month","weight":0.3408},{"period":"3month","weight":-0.5897},{"period":"6month","weight":-0.7832},{"period":"1year","weight":-0.9158},{"period":"ytd","weight":0.3714}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司，为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司，开发一种新的方法来治疗癌症，根据其新的专利技术平台，包括其最初的候选产品，Oncoprex免疫基因治疗提供，或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因，然后静脉内施用并被肿瘤细胞摄取，其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制，其中断细胞信号通路，其引起癌细胞的复制和增殖，重新建立癌细胞中凋亡途径或程序性细胞死亡途径，并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.715067},{"month":2,"riseRate":0.375,"avgChangeRate":0.055489},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.203799},{"month":4,"riseRate":0.375,"avgChangeRate":0.224041},{"month":5,"riseRate":0.5,"avgChangeRate":0.04274},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145852},{"month":7,"riseRate":0.25,"avgChangeRate":-0.142685},{"month":8,"riseRate":0.375,"avgChangeRate":-0.134978},{"month":9,"riseRate":0.125,"avgChangeRate":-0.162406},{"month":10,"riseRate":0.125,"avgChangeRate":0.45127},{"month":11,"riseRate":0.125,"avgChangeRate":-0.228987},{"month":12,"riseRate":0.375,"avgChangeRate":-0.063233}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}